Perspectives From Strategics — What on Your 2025 M&A, BD, and Corp Dev Agenda? | LSI USA '25

This panel took place at LSI USA '25 Emerging Medtech Summit in Dana Point, CA.Industry leaders from CONMED and KARL STORZ join Kx Advisors to discuss strategic priorities, trends, and insights shaping M&A, business development, and corporate development agendas for 2025.This panel featured:Daniel O'Neill — Kx AdvisorsPeter Shagory — CONMEDNate Harrington — Philips VenturesHelene Wahl — KARL STORZJoin us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summitsFollow us on social!LinkedIn: https://www.linkedin.com/company/life-science-intelligence/Twitter: https://twitter.com/lsintelligenceInstagram: https://www.instagram.com/lifescienceintelligence/Facebook: https://www.facebook.com/LifeScienceIntelligence/Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw

There are no comments yet.

Please log in to write the first comment.